ZiO Health specializes in the development of innovative biosensor technology that quantitatively analyzes various parameters in bodily and environmental fluids. The company offers a range of portable testing devices tailored for use in homes, hospitals, and other settings, aimed at enhancing health outcomes through molecular testing. Operating under the brands ELAPTA and ELOSIA, ZiO Health provides solutions such as ELOSIA, a home urine test designed to assess wellness parameters and deliver personalized nutrition and wellness advice. The company's devices facilitate the detection and measurement of chemical and biological substances, empowering users to optimize their health and prevent illness through effective home diagnostics and tailored testing solutions.
OptiChroniX is a Swiss digital therapeutics company focused on enhancing brain health at early stages. The company develops innovative digital health interventions that integrate biomedical, behavioral, computing, and engineering research. These interventions are accessible via smartphones, allowing patients to personalize their health tracking and monitor progress by gathering data from various wearables. OptiChroniX aims to provide tailored coaching to improve health literacy and medication adherence, while addressing modifiable risk factors that contribute to cognitive decline in patients with Alzheimer’s disease and related conditions. By optimizing lifestyle choices and making medicine more intelligent, OptiChroniX seeks to enhance clinical outcomes, improve quality of life, and increase the cost-effectiveness of treatment options.
PKvitality is a bio-wearable company based in Paris, France, founded in 2017. The company has developed K’Track, a line of trackers that utilize its patented SKinTaste technology to analyze physiological markers through non-invasive skin testing, eliminating the need for blood samples. One of its flagship products, K’Watch Glucose, enables diabetic individuals to monitor their glucose levels continuously and conveniently, without the discomfort associated with traditional blood tests. The wearable device features a sensor that requires no calibration, provides a comprehensive data history, and sends alerts to users to remind them to check their glucose levels, enhancing the self-monitoring experience for diabetic patients.
MiMARK focuses on improving the accuracy and efficiency of diagnostics for endometrial cancer, which is the sixth most commonly occurring cancer in women.1 As with many cancers, early and accurate detection of the disease is linked to increased survival, however currently around a third of endometrial cancer patients are diagnosed at the advanced stage.2 By improving the technology available for the diagnosis of endometrial cancer, MiMARK hopes to improve the speed and accuracy at which women can be diagnosed and effectively treated.
Orbit Health is a health technology company that develops an artificial intelligence platform aimed at improving the management of chronic diseases, particularly Parkinson's disease. The platform offers continuous and objective insights into motor symptoms by utilizing smartwatch motion data, which is passively collected without disrupting patients' daily activities. This data allows physicians to tailor treatment plans, enabling patients to achieve optimal symptom control and enhance their quality of life. By focusing on the personalization of treatment, Orbit Health seeks to address the unique needs of individuals living with Parkinson's disease.
Radiobotics are developing stellar machine learning algorithms, supporting doctors in analysing medical images, and making the right decisions.
Tympany Medical focuses on advancing minimally invasive ear surgeries through innovative technology. The company has developed a specialized ear surgery device that provides a sterile endoscopic solution for complex procedures in otolaryngology. This device addresses key challenges related to the usability and flexibility of traditional endoscopes, allowing surgeons to benefit from enhanced visualization while preserving their two-handed operating techniques. By reducing the necessity for mastoidectomies, Tympany Medical aims to improve surgical outcomes and streamline the process of ear surgeries, ultimately enhancing patient care in the field of ENT.
Biel Glasses, SL, founded in 2017 and based in Barcelona, Spain, specializes in developing and selling electronic smart glasses designed to enhance the mobility and personal autonomy of individuals with low vision. Recognizing that low vision is more prevalent than blindness and cannot be rectified with conventional glasses or surgery, the company focuses on addressing the mobility challenges faced by this population. The smart glasses utilize 3D vision and artificial intelligence algorithms to detect obstacles, while incorporating mixed reality technology to present information in a manner accessible to users' remaining vision. Additional features such as zoom and image enhancement provide a comprehensive solution aimed at improving the quality of life for those with low vision.
hemotune AG develops medical device for the purification of blood in acute care. The company uses magnetic blood purification on the device to treat infections. hemotune AG was founded in 2016 and is based in Zürich, Switzerland.
Ilya Pharma AB is a biotechnology company based in Uppsala, Sweden, that specializes in developing biological drugs aimed at treating wounds in skin and mucosa. Founded in 2016, the company focuses on addressing both acute and chronic wounds, particularly those affecting individuals with diabetes. Ilya Pharma employs a unique approach by genetically modifying lactic acid bacteria, commonly found in yogurt, to produce substances that enhance the healing process of skin injuries. Their innovative drug delivery system utilizes these bacteria as vectors to administer biological drugs directly at the wound site or within the gastrointestinal tract, facilitating accelerated healing in a cost-effective manner. The company’s research and development efforts are rooted in extensive scientific studies conducted at Uppsala University and the Swedish University of Agriculture.
MRIguidance is a spin-off company of UMC Utrecht developing the medical imaging technique BoneMRI. MRIguidance was founded in 2016 by MR physicist Peter Seevinck, image scientist Marijn van Stralen and entrepreneur Roel Raatgever. The first research resulting in the proprietary BoneMRI technology dates back to 2013. MRIguidance is an UtrechtInc graduate company.
HT BioImaging Ltd. is an innovative company that specializes in developing advanced medical imaging technology for the early detection of oral cancer. Founded in 2015 and headquartered in Ganei Am, Israel, the company produces the HTOScan, a device that utilizes heat diffusion imaging combined with artificial intelligence to assess tissue for cancerous changes. This technology translates heat distribution patterns into visual representations that indicate the likelihood of cancer, enabling prompt diagnosis. The team at HT BioImaging comprises experts in AI, signal analysis, computer vision, thermodynamics, and oncology, all working together to enhance cancer detection methods. The company's goal is to make its imaging solution widely available for use in community clinics and operating rooms, ultimately improving patient outcomes through early intervention.
Portabiles HealthCare Technologies specializes in high precision solutions for medical gait analysis. The company has developed a gait analysis system aimed at monitoring patients with chronic diseases. Utilizing a validated high-end algorithm, the system delivers clinical-grade gait parameters derived from daily activities. This information is accessible to therapists via a telehealth platform or smartphones, allowing them to obtain clinically relevant data that can inform and enhance therapy regimes.
Neurent Medical Limited is a medical device company based in Galway, Ireland, specializing in the development of innovative treatments for rhinitis. Founded in 2015, the company has created a single-use, minimally invasive device designed for ENT surgeons to address both allergic and non-allergic rhinitis. This hand-held, radio-frequency device is introduced through the nostrils into the nasal cavity under direct endoscopic visualization. It employs a microelectrode array to deliver targeted energy, interrupting the autonomic function of the mucosal structures in the nasal cavities. This approach helps reverse the inflammatory cascade, allowing for effective treatment in an office setting while minimizing the complications and costs commonly associated with traditional surgical procedures.
Oxford Endovascular are developing a novel treatment for treating brain aneurysms. The Oxford technology uses a special laser-cut metal alloy which has a shape-memory. It can be posted into a catheter during surgery, inserted into the brain and opened up into a tiny tube mesh (‘flow diverter’) that fits into the natural shape of the blood vessel. This diverts the blood away from the aneurysm, allowing it to heal.
Volumina Medical SA, based in Switzerland, specializes in the development, manufacture, and commercialization of innovative tissue reconstruction technologies for the reconstructive and plastic surgery markets. The company focuses on tissue engineering, creating injectable 3D scaffolds designed to restore soft tissue volumes, including fat, muscles, and glandular tissues. These scaffolds are particularly useful for patients who have experienced tissue loss due to tumor ablation, disease, or trauma, as well as for those seeking aesthetic enhancements. By utilizing thin cannulas for injection, Volumina's technologies aim to reduce both intervention and recovery times, facilitating more efficient and effective solutions for natural tissue repair.
Orthox Ltd. is a medical implant company based in Abingdon, United Kingdom, specializing in tissue regenerative implants for patients with knee injuries. Founded in 2008 by Dr. Nick Skaer and Professor Oliver Kessler, the company leverages silk technology developed at Oxford University to create innovative solutions for cartilage and meniscus repair. Its primary products include FibroFix, a biomaterial designed to replicate human knee cartilage; FibroFix Meniscus, which focuses on repairing and regenerating meniscal cartilage; and FibroFix Cartilage, aimed at treating articular cartilage damage. The technology behind these products was originally developed at Oxford Biomaterials Ltd., where Dr. Skaer played a significant role in advancing the FibroFix technology platform before securing exclusive licenses for its application in cartilage and bone repair.
Allcyte is a biotech start-up company focused on functional drug testing in primary human material. With our Pharmacoscopy high-content imaging platform and AI-supported image analysis pipelines, our mission is to bring the next generation of personalized medicine to cancer patients and treating physicians, and support pharmaceutical companies to focus their drug development efforts on the right molecules in the right indications. We enable research through the image-based quantification of single-cell phenotypes - all performed directly in primary patient material with minimal amounts of manipulation and requiring minimal amounts of sample. We integrate these data using cutting edge methods of statistics and machine learning to generate actionable insights for our customers. Our mission is to help you make the best possible biomedical decisions.
MOWOOT is a Non-pharmacological & Non-invasive solution for people suffering from chronic constipation. Its solution is a wearable medical device, which provides an automatic colon-specific massage similar to the manual abdominal massage administered by health professionals. MOWOOT utilizes advanced pneumatic technology to treat and prevent chronic slow transit constipation without colon cleansing supplements, enemas, and laxatives. The company emerged out of the MOEBIO dHEALTH program, which is inspired by Stanford Biodesign and Kaospilot Design and Business School from Denmark. MOWOOT was founded in 2014 and is based in Barcelona, Spain.
We use technology and a patient-first approach to democratize clinical trial access, so that every patient has the best chances of recovery and leading a healthy life.
Paragit Solutions is focused on improving the assessment of motor symptoms related to Parkinson's disease and enhancing the evaluation of new therapies. The company has developed a healthcare tracking device that employs artificial intelligence to monitor and quantify these symptoms. This device consists of a sleeve that records daily routine data, which is then stored in cloud storage. By enabling neurologists to access this data, Paragit facilitates more accurate treatment decisions for patients suffering from Parkinson's disease. This innovative approach aims to transform how patients are medicated and how their conditions are managed.
BOCAhealth is a patented portable device (connected to an app) that is able to measure and keep track of the hydration status of a user without the need for medical personnel.
Non Equity Assistance in 2020
SCARLETRED is an international digital health company focused on transforming the global skincare market with its innovative product, SCARLETRED®VISION. The company addresses the challenges of subjective skin assessment and the lack of standardization in dermatology through its CE-certified medical device, which operates via a mobile iOS application and connects to a web platform. This technology, recognized with the Austrian State Prize and the MedTech Award in Silicon Valley, facilitates standardized skin documentation and remote tracking. Users can upload images to a cloud-based platform for objective analysis of skin changes over time, such as allergic reactions, pigmentation shifts, acne, and wound healing. SCARLETRED provides its product and software-as-a-service to the biopharma and cosmetics industries, hospitals, and medical professionals. The application is fully compliant with Good Clinical Practice (GCP) and, when used in conjunction with SCARLETRED's proprietary Skin Patch, serves as a precise reference for color and size in clinical and research settings.
In modern healthcare, not only must we focus on prolonging a person's life, but also on maintaining the quality of that life. Functional health information is a powerful tool enabling clinicians to maintain patient quality of life, but it is let down by imperfect assessment tools that are subjective, have poor repeatability and are insensitive to incremental change. Vitrue is a huge leap in functional assessment accuracy and efficiency. Our system will enable occupational and physical therapists to treat more patients, more effectively by providing them with far more advanced and modern assessment tools.
Hygiene Audits specializes in providing software solutions aimed at enhancing infection prevention and control within nursing homes and healthcare facilities. Their platform features automated workflows that assist care staff in tracking and managing infection risks, thereby contributing to the reduction of healthcare-associated infections. The software includes digital audit tools that facilitate compliance with national hygiene standards, allowing institutions to effectively monitor their environmental hygiene practices. By focusing on risk management and compliance, Hygiene Audits empowers healthcare providers to create safer environments for both patients and staff.
VineHealth Digital Limited operates an online platform that uses behavioral science and AI to increase the survival of cancer patients. Its platform allows users to track their symptoms, side effects, and activities to understand how they are feeling; connects them with like-minded people; and provide the information that they need to understand about their care. The company was founded in 2018 and is based in London, United Kingdom.
SurgiQ focuses on improving surgical pathways to enhance efficiency and reduce invasiveness for patients and healthcare providers. The company offers an innovative audit and planning platform that leverages AI algorithms to help healthcare providers track, learn, and prioritize surgical procedures. By streamlining these processes, SurgiQ aims to minimize inefficiencies in surgical care, ultimately facilitating timely interventions and improving outcomes for patients and their families.
AquAffirm develops a user-friendly web-based tool employing sophisticated models for analyzing both epidemic trajectory and restriction management of COVID-19. The solution will allow even small businesses and developing countries to access advanced prediction models.
Waytob is an accessible travel platform designed to assist individuals with intellectual disabilities. The company has developed a navigation application that aims to make travel more accessible for everyone, regardless of their abilities. This application utilizes assistive technology to offer directions on a smartwatch, ensuring users receive real-time guidance. Additionally, it provides critical information regarding safe crossing points, enhancing user safety while navigating their environment. The platform also includes features that allow family members to monitor the location of users, promoting independent travel for those with higher support needs. Through these innovative solutions, Waytob seeks to empower individuals to explore the world with greater confidence and autonomy.
SepTec is developing and commercializing a revolutionary sample-to-answer sepsis diagnostic device that can rapidly detect pathogens in whole blood.
BioXplor, Inc. is a research and development company based in Berkeley, California, founded in 2017. It specializes in an augmented intelligence platform that facilitates data-driven hypotheses generation and predictions in biomarker and drug discovery. The company leverages big data, artificial intelligence, and high-performance computing to enhance the interpretation of unstructured literature and structured multi-omics data. BioXplor focuses on both in-house and external projects, with particular attention to AI-assisted biomarker discovery, molecular target identification, and drug repurposing, primarily in the fields of cancer and rare diseases.
CrannMed aims to eliminate chronic pain, restore mobility, and stop disease progression for patients with knee osteoarthritis. Their solution provides an alternative treatment for this debilitating disease through the development of bioresorbable embolic particles and a balloon occlusion microcatheter.
Upstream Health employs AI combined with a mobile and analytics platform to provide innovative technologies and new service approaches that support an “upstream” approach, encouraging better preventive care.
CapBuster is a medical device company that has developed an innovative balloon catheter and guidewire combination designed to assist physicians in effectively treating challenging occlusions, particularly those with calcified caps. This device leverages a unique screw-thread mechanism, allowing for enhanced penetration through stubborn blockages while utilizing standard angioplasty tools and techniques familiar to medical practitioners. By offering a simple, fast, and cost-effective solution, CapBuster minimizes the need for extensive training and eliminates the requirement for additional capital equipment in hospitals. The device aims to improve the safety and efficacy of procedures, ultimately reducing the time needed for interventions involving blocked arteries.
NUA Surgical is an award-winning start-up based at the National University of Ireland it develops a specialized surgical retractor to make C-Sections a safer and superior surgery.SteriCISION will improve the ergonomics of the surgery, reduce the resources required and reduce the risk of surgical site infection.
Neomimix specializes in biomimicry technology aimed at enhancing assisted human reproduction. The company has developed an innovative microfluidics platform that simulates the female reproductive tract, allowing for the natural selection of sperm. This process focuses on sorting and selecting high-quality sperm with minimal DNA fragmentation, thereby improving reproductive outcomes. The technology employs a disposable chip component, ensuring a simple and fully traceable method for sperm selection. Through its solutions, Neomimix aims to provide a more effective approach to fertility treatments.
uFraction8 specializes in scalable bioprocessing technology that enhances biomass filtration, separation, and dewatering. The company's innovative approach utilizes microfluidic devices to efficiently process a wide range of microbes, including microalgae, yeast, and bacteria. Unlike traditional methods such as centrifuges, filters, and membranes, uFraction8's technology sorts biomass from culture media without causing harm and without the use of flocculants. This advanced cell separation technology enables industries to achieve higher throughput and reduce costs compared to conventional liquid processing methods. By focusing on industrial-scale applications, uFraction8 provides solutions that streamline operations in various sectors while maintaining efficiency and effectiveness.
KroniKare AI-based system helps with early detection of complications such as infection, undermining and blood circulation problems. This can significantly reduce costs for chronic wound care from faster recovery of patients to productivity gains and upskilling of junior nurses.
BeneTalk, now known as Respira Ltd, is a speech therapy technology company that specializes in developing wearable digital speech devices aimed at assisting individuals who stutter. The company offers a unique wearable device that monitors breathing and speech patterns, providing real-time feedback and tracking performance history to support users in everyday situations outside of clinical settings. This device includes a belt that vibrates when the user does not utilize proper diaphragmatic breathing and analyzes speaking habits throughout the day. Additionally, an accompanying app records performance history and delivers visual or haptic feedback on breathing and phonation, while also setting personalized goals to help users cultivate effective communication habits. Founded in 2015 and based in London, the company rebranded from BeneTalk to Respira Ltd in June 2020, reflecting its commitment to innovative solutions in fluency therapy.
Latch Medical eases catheter use through the development of Cath Latch, a patented microneedle technology that allows robust, adhesive-free, and non-invasive catheter securement to the skin. The solution allows the device to stay in situ for extended periods of time with a low risk of complications.
Oncochain is developing a real-world data platform in oncology to standardize, collect and aggregate anonymized data from patients who suffer from cancer. This creates the possibility to generate useful analytics that can orientate research for pharma companies and help healthcare providers deliver value-based care. Our proprietary method of collection is a web-based Oncology specific EHR that acts as a software platform creating operational data repositories for RWD studies. We greatly aid the informational flow between providers and upskill oncology professionals. We support research by reducing recruitment times in clinical trials and by creating the necessary framework for multi-centric studies design and implementation. Oncochain SaaS Analytics Tool offers much-needed RWD insights for clients like pharma companies and CROs.
Biel Glasses, SL, founded in 2017 and based in Barcelona, Spain, specializes in developing and selling electronic smart glasses designed to enhance the mobility and personal autonomy of individuals with low vision. Recognizing that low vision is more prevalent than blindness and cannot be rectified with conventional glasses or surgery, the company focuses on addressing the mobility challenges faced by this population. The smart glasses utilize 3D vision and artificial intelligence algorithms to detect obstacles, while incorporating mixed reality technology to present information in a manner accessible to users' remaining vision. Additional features such as zoom and image enhancement provide a comprehensive solution aimed at improving the quality of life for those with low vision.
ABLE Human Motion SL, founded in 2018 and based in Barcelona, Spain, is a medical device company focused on developing robotic exoskeletons for individuals with lower-limb paralysis. Originating as a spin-off from Universitat Politècnica de Catalunya, the company aims to enhance the mobility and independence of people with disabilities. Its innovative technology employs a motor and gearbox that simulate muscle function, along with an inertial sensor to interpret the user's intentions. This approach not only empowers individuals in wheelchairs by improving their mobility but also serves as a valuable tool for clinicians to enhance rehabilitation efficiency.
Menutech is a B2B SaaS company focused on transforming the foodservice technology sector through AI-driven menu planning personalization. Its platform caters to food and beverage managers, dieticians, and nursing staff by automating the creation of meal plans tailored to individual dietary needs. This innovative solution significantly reduces the time required to prepare personalized meal plans by up to 90%, thereby minimizing health risks and lowering procurement costs for hospitals, senior homes, and hospitality businesses. Menutech's software also ensures safe menu planning by coordinating ingredient lists with allergen information and detecting potential allergens in recipes, allowing clients to manage daily or special menus effectively and safely.
Sleepiz AG is a Zurich-based startup focused on developing innovative solutions for sleep disorder screening and chronic disease management. Founded in 2018, Sleepiz manufactures a non-contact sleep monitoring device that can be placed on a bedside table. This device utilizes advanced wireless millimeter wave technology, sensor fusion, and artificial intelligence to accurately track vital parameters such as breathing, heart rate, and body movements. By enabling real-time assessment of sleep patterns and long-term monitoring, Sleepiz aims to facilitate timely interventions and enhance treatment outcomes for patients. The company's mission is to support the medical community in transitioning healthcare into home environments, allowing for more accessible and patient-centric care.
PIPRA AG (Pre-Interventional Preventive Risk assessment) is developing a cutting-edge AI-based pre-operative test to assess patient's risk of suffering from cognitive disorders after a surgery.
iLoF - Intelligent Lab on Fiber is a company based in Porto, Portugal, founded in 2019, that specializes in developing a cloud-based platform aimed at accelerating drug discovery, particularly for Alzheimer's treatment. By utilizing advanced photonics and artificial intelligence, iLoF identifies unique features of key biomarkers and captures their signatures in a digital library. This innovative approach enables the collection of extensive biological data, facilitating the creation of individualized treatment plans. The platform aims to streamline clinical trials, making them more cost-effective, convenient, and focused on patient needs, thereby advancing the field of personalized medicine.
The Oxford Foundry is a centre for entrepreneurial growth, embedded in the University of Oxford. It focuses on venture creation and growth, and on harnessing talent to create solutions to global challenges.
TeiaCare is an Italian start-up founded in 2018, focused on enhancing technology and innovation in care homes. Based in Milan, the company operates in Italy and Spain and has a team of 15 employees supported by international investors. TeiaCare's primary product, Ancelia, is an AI-powered operating system that aims to improve transparency in care processes for residents and their families. This health technology solution includes a virtual assistant that generates smart alerts, reminders, and reports, addressing inefficiencies in monitoring post-acute hospital patients in nursing homes. Through its innovative approach, TeiaCare seeks to optimize resident assistance and streamline care home operations.
BeSure Online is a digital platform for daily aging patients’ monitoring, stroke risk mitigation, clinical decision support, and health plans optimization. Using data from wearable devices, IoT and medical equipment, as well as external data, BeSure makes real-time analysis of leading health indicators in order to predict the onset of emergent situations and evaluate health outcomes Precise COVID19: remote patients monitoring and clinical decision support system for healthcare providers with coronavirus COVID-19 patients
Sleepiz AG is a Zurich-based startup focused on developing innovative solutions for sleep disorder screening and chronic disease management. Founded in 2018, Sleepiz manufactures a non-contact sleep monitoring device that can be placed on a bedside table. This device utilizes advanced wireless millimeter wave technology, sensor fusion, and artificial intelligence to accurately track vital parameters such as breathing, heart rate, and body movements. By enabling real-time assessment of sleep patterns and long-term monitoring, Sleepiz aims to facilitate timely interventions and enhance treatment outcomes for patients. The company's mission is to support the medical community in transitioning healthcare into home environments, allowing for more accessible and patient-centric care.
Smiletronix offers a home dental checkup solution that addresses the global challenge of untreated dental diseases, which impose a significant economic burden estimated at nearly $450 billion annually. The company has developed a handheld device and dental application that allows users to conduct a comprehensive dental health scan in under a minute, detecting issues such as cavities, gum disease, plaque, and tooth erosion. By facilitating at-home dental care, Smiletronix aims to promote preventative measures over curative treatments, which can lead to substantial cost savings for healthcare payers and enhance the long-term health of patients. Through its innovative intraoral imaging device and AI-powered diagnostics, Smiletronix is transforming the management of dental health.
BrachyDOSE is a cancer treatment quality control tool to help oncologists to reach best possible treatment results. For the oncologist the main problem performing radiotherapy procedure is lack of accurate and measurements based proof if tumor got the appropriate radiation dose, if healthy organs were damaged or stayed safe. The uncertainty leads to radiation burning and secondary illnesses. Solution is suited specially for high dose rate brachytherapy procedure. We suggest the systems made of tool for radiation dose measurement (dosimeter) and its reader. Unlike other solutions in the market, which is dose simulation apps, our system shows the accurate science based data, is easy to use and it is highly compatible with standards devices. Our team is made of materials engineer, applied physicist, medical device engineer and a few medical doctors working in oncology field. We are focused on radiation sensitive materials research and device engineering +7 years. We have +10 years of experience in project leadership and scientific research. Team members has experience in development of successful projects with Lithuanian Health Science University Kaunas Clinics, National Cancer Institute (Lithuania).
Ergobyte Informatics S.A. is a software development company that specializes in commercial products and services and custom application development. It conducts research in various fields of ICT such as computer aided diagnosis, knowledge representation, machine learning, and data analytics. The company develops off the shelf software products and information systems addressing the needs of the medical sector. The company has created Galen, a popular online drug database for all matters concerning human pharmacology. The company designs applications for smartphones and portable devices such as PDA and tablets. The applications are supported by both iPhone and Android platforms. Ergobyte Informatics S.A. was founded by George Nikolaidis in 2002 and is headquartered in Thessaloniki, Greece.
Biel Glasses, SL, founded in 2017 and based in Barcelona, Spain, specializes in developing and selling electronic smart glasses designed to enhance the mobility and personal autonomy of individuals with low vision. Recognizing that low vision is more prevalent than blindness and cannot be rectified with conventional glasses or surgery, the company focuses on addressing the mobility challenges faced by this population. The smart glasses utilize 3D vision and artificial intelligence algorithms to detect obstacles, while incorporating mixed reality technology to present information in a manner accessible to users' remaining vision. Additional features such as zoom and image enhancement provide a comprehensive solution aimed at improving the quality of life for those with low vision.
Sleepiz AG is a Zurich-based startup focused on developing innovative solutions for sleep disorder screening and chronic disease management. Founded in 2018, Sleepiz manufactures a non-contact sleep monitoring device that can be placed on a bedside table. This device utilizes advanced wireless millimeter wave technology, sensor fusion, and artificial intelligence to accurately track vital parameters such as breathing, heart rate, and body movements. By enabling real-time assessment of sleep patterns and long-term monitoring, Sleepiz aims to facilitate timely interventions and enhance treatment outcomes for patients. The company's mission is to support the medical community in transitioning healthcare into home environments, allowing for more accessible and patient-centric care.
Elypta AB is a molecular diagnostic company based in Stockholm, Sweden, focused on developing a metabolism-based liquid biopsy platform for the early detection and monitoring of cancer. Founded in 2017, Elypta's platform utilizes a new in vitro diagnostic laboratory assay kit to measure biomarkers in blood and urine, employing artificial intelligence algorithms to analyze data for cancer signatures. The company is actively involved in the clinical trial series AURORAX, which investigates the application of its technology in renal cell carcinoma, addressing aspects such as recurrence surveillance and treatment response monitoring. Elypta is exploring its platform's potential across various cancer indications, aiming to enhance early-stage cancer detection and improve patient outcomes.
TeiaCare is an Italian start-up founded in 2018, focused on enhancing technology and innovation in care homes. Based in Milan, the company operates in Italy and Spain and has a team of 15 employees supported by international investors. TeiaCare's primary product, Ancelia, is an AI-powered operating system that aims to improve transparency in care processes for residents and their families. This health technology solution includes a virtual assistant that generates smart alerts, reminders, and reports, addressing inefficiencies in monitoring post-acute hospital patients in nursing homes. Through its innovative approach, TeiaCare seeks to optimize resident assistance and streamline care home operations.
ABLE Human Motion SL, founded in 2018 and based in Barcelona, Spain, is a medical device company focused on developing robotic exoskeletons for individuals with lower-limb paralysis. Originating as a spin-off from Universitat Politècnica de Catalunya, the company aims to enhance the mobility and independence of people with disabilities. Its innovative technology employs a motor and gearbox that simulate muscle function, along with an inertial sensor to interpret the user's intentions. This approach not only empowers individuals in wheelchairs by improving their mobility but also serves as a valuable tool for clinicians to enhance rehabilitation efficiency.
RemAb Therapeutics specializes in the development of polymeric glycoconjugate molecules aimed at addressing nosocomial infections. The company's innovative technology focuses on eliminating non-neutralizing natural antibodies that hinder the immune system's natural response and promote pathogen proliferation. By targeting these antibodies, RemAb Therapeutics seeks to provide medical practitioners with effective new strategies for both treating and preventing a range of pathological infections, enhancing patient outcomes in the process.
SensArs is an innovative startup based at EPFL, founded by Francesco Petrini, Stanisa Raspopovic, and Silvestro Micera, dedicated to enhancing the quality of life for amputees and individuals with nerve injuries. With nearly five million amputees and a significant number of nerve-injured persons in the USA and Europe, many suffer from neuropathic pain and a lack of sensory feedback, which hampers their ability to control prosthetic devices. SensArs aims to address these challenges by developing a patented implantable neurostimulator electrode that delivers precise electrical impulses to nerve fibers, restoring sensory feedback and improving functionality. This technology not only seeks to alleviate phantom limb pain but also enables users to feel their prosthetic limbs as part of their own bodies. By merging expertise in microtechnologies, algorithms, and clinical experimentation, SensArs is poised to revolutionize the prosthetics market by providing a solution that integrates sensory-motor functionality, thereby meeting the growing needs of amputees and nerve-damaged individuals.
STENTiT is a company that specializes in the development of regenerative stents aimed at restoring arteries. Its primary focus is on creating biodegradable endovascular implants that promote a natural healing response in patients. These innovative stents facilitate the circulation of blood cells, which work to replace the implant with new vascular tissue, effectively restoring the artery from the inside. By offering these advanced medical solutions, STENTiT enables healthcare professionals to treat patients suffering from cardiovascular diseases more effectively.
Nanoleq AG is a Swiss technology startup founded in 2017 and based in Zurich. The company specializes in the development and manufacture of electric cables utilizing stretchable electronics and innovative conductive materials. Nanoleq's cables are designed to serve various sectors, including healthcare, robotics, aerospace, and electronics. These cables function both as shields and conductors, offering exceptional electrical properties, high mechanical flexibility, and extended durability. Through its cutting-edge approach, Nanoleq aims to revolutionize cable technology and address the evolving needs of diverse industries.
Sleepiz AG is a Zurich-based startup focused on developing innovative solutions for sleep disorder screening and chronic disease management. Founded in 2018, Sleepiz manufactures a non-contact sleep monitoring device that can be placed on a bedside table. This device utilizes advanced wireless millimeter wave technology, sensor fusion, and artificial intelligence to accurately track vital parameters such as breathing, heart rate, and body movements. By enabling real-time assessment of sleep patterns and long-term monitoring, Sleepiz aims to facilitate timely interventions and enhance treatment outcomes for patients. The company's mission is to support the medical community in transitioning healthcare into home environments, allowing for more accessible and patient-centric care.
Sleepiz AG is a Zurich-based startup focused on developing innovative solutions for sleep disorder screening and chronic disease management. Founded in 2018, Sleepiz manufactures a non-contact sleep monitoring device that can be placed on a bedside table. This device utilizes advanced wireless millimeter wave technology, sensor fusion, and artificial intelligence to accurately track vital parameters such as breathing, heart rate, and body movements. By enabling real-time assessment of sleep patterns and long-term monitoring, Sleepiz aims to facilitate timely interventions and enhance treatment outcomes for patients. The company's mission is to support the medical community in transitioning healthcare into home environments, allowing for more accessible and patient-centric care.
TeiaCare is an Italian start-up founded in 2018, focused on enhancing technology and innovation in care homes. Based in Milan, the company operates in Italy and Spain and has a team of 15 employees supported by international investors. TeiaCare's primary product, Ancelia, is an AI-powered operating system that aims to improve transparency in care processes for residents and their families. This health technology solution includes a virtual assistant that generates smart alerts, reminders, and reports, addressing inefficiencies in monitoring post-acute hospital patients in nursing homes. Through its innovative approach, TeiaCare seeks to optimize resident assistance and streamline care home operations.
Biel Glasses, SL, founded in 2017 and based in Barcelona, Spain, specializes in developing and selling electronic smart glasses designed to enhance the mobility and personal autonomy of individuals with low vision. Recognizing that low vision is more prevalent than blindness and cannot be rectified with conventional glasses or surgery, the company focuses on addressing the mobility challenges faced by this population. The smart glasses utilize 3D vision and artificial intelligence algorithms to detect obstacles, while incorporating mixed reality technology to present information in a manner accessible to users' remaining vision. Additional features such as zoom and image enhancement provide a comprehensive solution aimed at improving the quality of life for those with low vision.
GlyCardial Diagnostics S.L. develops point-of-care device that detects abnormal levels of Apo J-Glyc protein in the blood. It provides an accurate test to allow healthcare decisions. The company also develops a biomarker to detect ischaemic attack before it happens and address unmet medical need to identify patients at risk of having a repeat cardiovascular event. GlyCardial Diagnostics S.L. was founded in 2017 and is based in Barcelona, Spain.
Delox is a company based in Cascais, Portugal, specializing in the design and development of bio-decontamination devices aimed at creating clean and safe environments. Founded in 2018 as a spin-off from the Faculty of Sciences of the University of Lisbon, Delox focuses on non-toxic bio-decontamination solutions that effectively combat microorganisms. The company’s portfolio includes automatic biodecontamination robots tailored for various applications, such as sterilizing medical devices in hospitals and health centers, room decontamination in healthcare, pharmaceuticals, food industries, and even in space environments. Delox utilizes an innovative formulation of solid hydrogen peroxide, enhancing the efficiency and affordability of its bio-decontamination systems, which also serve laboratory equipment and humanitarian missions in challenging conditions.
Inovus Ltd specializes in designing and manufacturing medical simulation products aimed at enhancing surgical training. Founded in 2012 and based in Saint Helens, United Kingdom, the company offers a range of simulators, including take-home and institutional laparoscopic simulators. These products are specifically developed to teach essential surgical skills, such as laparoscopic appendectomy and cholecystectomy, as well as competencies in critical care and medicine. Inovus Ltd caters to its customers primarily through online channels, providing accessible and versatile training solutions for surgical trainees and residents to improve their skills and ultimately enhance patient care.
Helping people with diabetes manage their insulin doses.
Non Equity Assistance in 2018
We develop a new PET scanner technology that reduces costs significantly, enabling a wider use of PET by research, training and diagnostic imaging centers. Our mission is to increase access to PET imaging around the world, by providing uniquely affordable, high resolution compact systems. Our motto: keep PET simple!
Climedo Health GmbH is a Munich-based company that specializes in developing a research database for medical research. Founded in 2017, Climedo offers a cloud-based platform that facilitates the digital collection and management of clinical data. Its products include an Electronic Patient Record, Electronic Laboratory Management, and Electronic Research Management systems, which integrate both structured and unstructured research data into a single privacy-compliant database. By connecting various stakeholders such as medical device manufacturers, pharmaceutical companies, clinical research organizations, hospitals, and patients, Climedo enhances the efficiency and performance of clinical research. This collaboration aims to improve patient treatment quality and accelerate medical innovation through data-driven insights.
nevisQ provides a smart sensor system that allows discreet room activity analysis. Nursing homes face big challenges, especially due to the lack of nurses. At nevisQ, they support nurses and residents of nursing homes with the help of their unique sensor strip. The sensor strip is attached a few centimeters over the ground on the height of baseboards around the room and can detect and analyze activities in rooms automatically, like falls, getting up from the bed, long toilet stays or changes in the activity pattern of residents. Thus, nurses can work more efficiently and residents feel safer. Residents thereby do not have to wear any item with them, and no high-resolution data is processed. So this solution creates the balance between precision and privacy.
Oxford Heartbeat develop medical device software that makes planning for surgeries simpler, faster and more accurate. It enables surgeons to unlock and visualise crucial information in preparation for surgery, to see what is happening inside blood vessels, travel through tissues and bones and provides unprecedented visibility for keyhole surgeries. With the combined power of predictive computations, big data and AI, they provide a unique solution for rehearsing procedures and choosing the best surgical scenario for each individual patient in advance. Better preparation means reduced complication rates and associated costs, as well as better patient care.
Rethink Medical is a medical company focused on developing innovative solutions to address various health challenges. The company aims to create new remedies and enhance existing medical technologies. Its initial product, the T-Control Urinary Catheter, exemplifies this mission by improving patient care and comfort in urinary management. Rethink Medical operates within the medical device sector, striving to deliver effective and user-friendly healthcare products.
2Eyes Vision S.L is a technology company based in Madrid, Spain, specializing in visual diagnostics and corrections. Founded in 2015 as a spin-off from the Spanish National Research Council (CSIC), it focuses on addressing presbyopia, an age-related ocular condition affecting individuals over 45 years old. The company's flagship product, SimVis, is a pioneering technology that allows patients to experience multifocal corrections in real-world scenarios prior to undergoing intraocular lens implantation, refractive surgery, or contact lens fitting. This innovative visual simulator enhances the clinical practice of ophthalmology by enabling opticians to provide personalized, noninvasive assessments for patients considering refractive or cataract surgery, ultimately improving patient outcomes and experiences.
Aelix Therapeutics SL is a biotechnology company based in Barcelona, Spain, focused on developing therapeutic vaccines and immunotherapies for the treatment of HIV infection. Established in 2015, Aelix Therapeutics emerged as a spin-off from HIVACAT, a Catalan initiative aimed at creating effective HIV vaccines. The company is led by a team of experienced professionals in the fields of HIV and biotechnology, including Dr. Christian Brander, Bonaventura Clotet, Josep Maria Gatell, and Jordi Naval. Aelix Therapeutics leverages innovative immunogen designs to enhance its therapeutic approaches and has established partnerships that provide access to extensive cohorts of HIV-infected patients across various continents, facilitating clinical research and development. The company's vaccine strategy is based on a T-cell immunogen that has the potential to elicit strong immune responses, aiming to transform the treatment landscape for HIV and improve patient outcomes.
Onalabs is the first non-invasive monitoring solution measuring any chemical parameters present in sweat using miniaturized biosensors. It provides Point-of-Care (POC) technologies, designed to provide rapid clinical diagnosis at, or near the site of patient care. Its non-invasive products based on wearable formats empower the patients and their families to measure relevant biomarkers anytime and anywhere, allowing them to detect and monitor early stages of possible clinical deterioration, which could prelude in earlier (self-)management strategies, resulting in shorter hospital stays and prevention of unnecessary treatments.
AVX Pharma is a biopharmaceutical company dedicated to developing innovative treatments for significant ophthalmic unmet medical needs, particularly ocular surface diseases. Founded in July 2013, the company emerged from neurobiological research led by Professor Carlos Belmonte at the Instituto de Neurociencias de Alicante. Based in Barcelona, AVX Pharma specializes in creating advanced medicinal products aimed at improving recovery times for conditions such as dry eye syndrome, thereby enhancing patient outcomes in the field of ophthalmology.
MetaHeps GmbH provides consulting and solutions for drug-induced liver injury (DILI) in clinical drug-development and postmarketing. It is a unique service provider that generates a personalized cell model reflecting individual drug hepatotoxicity from a small patient blood sample. Customers are research driven pharmaceutical companies and global acting CROs, using Metaheps’ services in clinical phases of drug development as well as postmarketing to diagnose or exclude Druginduced liver injury (DILI) in individual patients. MetaHeps vision is to increase access of patients to novel drugs by addressing DILI issues in drug development in an unrivaled and innovative approach.
NUA Surgical is an award-winning start-up based at the National University of Ireland it develops a specialized surgical retractor to make C-Sections a safer and superior surgery.SteriCISION will improve the ergonomics of the surgery, reduce the resources required and reduce the risk of surgical site infection.